نتایج جستجو برای: icos

تعداد نتایج: 1018  

2015
Mara Kornete Edward S. Mason Julien Girouard Erin I. Lafferty Salman Qureshi Ciriaco A. Piccirillo

Type 1 diabetes (T1D) occurs through a breakdown of self-tolerance resulting in the autoimmune destruction of the insulin producing β-islets of the pancreas. A numerical and functional waning of CD4+ Foxp3+ regulatory T (Treg) cells, prompted by a pancreatic IL-2 deficiency, accompanies Th1 autoimmunity and T1D progression in non-obese diabetic (NOD) mice. Recently, we identified a dominant sub...

Journal: :Folia histochemica et cytobiologica 2011
Lidia Karabon Anna Jedynak Anna Tomkiewicz Dariusz Wolowiec Marek Kielbinski Dariusz Woszczyk Kazimierz Kuliczkowski Irena Frydecka

There is strong evidence that altered immunological function entails an increased risk of B-cell chronic lymphocytic leukemia (B-CLL). The main mechanism of an anti-tumor response depends on T-cell activation. Unlike the constitutively expressed CD28, inducible costimulatory molecule (ICOS) is expressed on the T-cell surface after activation. ICOS enhances all the basic T-cell responses to a fo...

Journal: :Journal of immunology 2006
Eric C Logue Sonia Bakkour Michael M Murphy Hector Nolla William C Sha

We report in this study that B7h, the ligand for the ICOS costimulatory receptor, is rapidly shed from mouse B cells following either ICOS binding or BCR engagement. Shedding occurs through proteolytic cleavage that releases the extracellular ICOS-binding region of B7h. Prior exposure of B7h-expressing APCs to ICOS-expressing cells inhibits their subsequent ability to costimulate IFN-gamma and ...

2014
Xiaozhou Fan Sergio A. Quezada Manuel A. Sepulveda Padmanee Sharma James P. Allison

Cytotoxic T lymphocyte antigen-4 (CTLA-4) blockade with a monoclonal antibody yields durable responses in a subset of cancer patients and has been approved by the FDA as a standard therapy for late-stage melanoma. We recently identified inducible co-stimulator (ICOS) as a crucial player in the antitumor effects of CTLA-4 blockade. We now show that concomitant CTLA-4 blockade and ICOS engagement...

2000
CHRISTOF MONZ

The first workshop on Inference in Computational Semantics (ICoS-1) was held at the Institute for Logic, Language and Computation of the University of Amsterdam, on August 15, 1999. It was aimed at bringing together researchers from scientific disciplines to discuss approaches and applications of inference in natural language semantics, ranging from theoretical to implementational issues. In pa...

2017
Claire Briet Gwladys Bourdenet Ute C. Rogner Chantal Becourt Isabelle Tardivel Laurent Drouot Christophe Arnoult Jean-Claude do Rego Nicolas Prevot Charbel Massaad Olivier Boyer Christian Boitard

Abrogation of ICOS/ICOS ligand (ICOSL) costimulation prevents the onset of diabetes in the non-obese diabetic (NOD) mouse but, remarkably, yields to the development of a spontaneous autoimmune neuromyopathy. At the pathological level, ICOSL-/- NOD mice show stronger protection from insulitis than their ICOS-/- counterparts. Also, the ICOSL-/- NOD model carries a limited C57BL/6 region containin...

Journal: :Journal of immunology 2006
Lukas Bossaller Jan Burger Ruth Draeger Bodo Grimbacher Rolf Knoth Alessandro Plebani Anne Durandy Ulrich Baumann Michael Schlesier Andrew A Welcher Hans Hartmut Peter Klaus Warnatz

ICOS is expressed on activated T cells and particularly on CXCR5+ follicular Th cells in germinal centers (GC). Its deletion leads to a profound deficiency in memory B cell formation and switched Ab response in humans. Here, we show that in ICOS-deficient patients the generation of GCs is severely disturbed, and the numbers of circulating CXCR5+CD45RO+ memory CD4 T cells are significantly reduc...

2010
Natalia Martin-Orozco Yufeng Li Yijun Wang Shijuan Liu Patrick Hwu Yong-Jun Liu Laszlo Radvanyi

CD4þCD25þFoxp3þ T-regulatory cells (Tregs) accumulate in tumors; however, little is known about how the tumor environment influences this process. Here we show that human melanomas express inducible T-cell costimulator ligand (ICOS-L/B7H) that can provide costimulation through ICOS for the expansion of activated Tregs maintaining high Foxp3 and CD25 expression as well as a suppressive function....

Journal: :Biochemical and biophysical research communications 2000
K Tezuka T Tsuji D Hirano T Tamatani K Sakamaki Y Kobayashi M Kamada

Activation-inducible lymphocyte immuno-mediatory molecule (AILIM) is an inducible cell surface glycoprotein expressed on thymocytes and activated lymphocytes. Specific monoclonal antibody to rat AILIM induced the cell aggregation of a rat thymoma cell line and ConA-activated splenocytes. In the present study, we identified the primary structure of two species of rat AILIM by expression cloning....

Journal: :The Journal of clinical investigation 2003
Roza I Nurieva Piper Treuting Julie Duong Richard A Flavell Chen Dong

CD4(+) helper Th cells play a major role in the pathogenesis of rheumatoid arthritis. Th cell activation, differentiation, and immune function are regulated by costimulatory molecules. Inducible costimulator (ICOS) is a novel costimulatory receptor expressed on activated T cells. We, as well as others, recently demonstrated its importance in Th2 cytokine expression and Ab class switching by B c...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید